Associated Papers
GASDERMIN D-mediated pyroptosis as a therapeutic target in TAU-dependent frontotemporal dementia mouse model.
Silva-Llanes I et al.
Journal of Biomedical Science, 2026
Genetic testing for Parkinson's disease in Israel: Insights from the Rostock Parkinson's Disease (ROPAD) study.
Anis S et al.
Parkinsonism & Related Disorders, 2025
Targeting CB2 receptor with a novel antagonist reverses cognitive decline, neurodegeneration and pyroptosis in a TAU-dependent frontotemporal dementia mouse model.
Silva-Llanes I et al.
Brain, Behavior, and Immunity, 2025
Population-Specific Differences in Pathogenic Variants of Genes Associated with Monogenic Parkinson's Disease.
Flores-Ocampo V et al.
Genes, 2025
40282414 (PubMed )
Supplement: genes-16-00454-s001.zip › Supplementary_Tables.xlsx › ST2
MAPT mutations in amyotrophic lateral sclerosis: clinical, neuropathological and functional insights.
De Bertier S et al.
Journal of Neurology, 2025
Clinical and Pathological Features of FTDP-17 with MAPT p.K298_H299insQ Mutation.
Morino H et al.
Movement Disorders Clinical Practice, 2024
A selection and optimization strategy for single-domain antibodies targeting the PHF6 linear peptide within the tau intrinsically disordered protein.
Mortelecque J et al.
The Journal of Biological Chemistry, 2024
Dissecting the Clinical Heterogeneity and Genotype-Phenotype Correlations of MAPT Mutations: A Systematic Review.
Villa C et al.
Frontiers in Bioscience (landmark Edition), 2024
RIPK1 expression and inhibition in tauopathies: implications for neuroinflammation and neuroprotection.
Silva-Llanes I et al.
Frontiers in Neuroscience, 2024
Conformational fingerprinting of tau variants and strains by Raman spectroscopy.
Devitt G et al.
Rsc Advances, 2021
Heparin-induced tau filaments are polymorphic and differ from those in Alzheimer's and Pick's diseases.
Zhang W et al.
Elife, 2019
Clinicopathologic heterogeneity in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) due to microtubule-associated protein tau (MAPT) p.P301L mutation, including a patient with globular glial tauopathy.
Tacik P et al.
Neuropathology and Applied Neurobiology, 2017
Mutation Frequency of the Major Frontotemporal Dementia Genes, MAPT, GRN and C9ORF72 in a Turkish Cohort of Dementia Patients.
Guven G et al.
Plos One, 2016
Novel mutation in MAPT exon 13 (p.N410H) causes corticobasal degeneration.
Kouri N et al.
Acta Neuropathologica, 2014
New mutations in MAPT gene causing frontotemporal lobar degeneration: biochemical and structural characterization.
Rossi G et al.
Neurobiology of Aging, 2012
Select a paper to view details